These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19788931)

  • 1. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
    Sweis R; Anggiansah A; Wong T
    Clin Gastroenterol Hepatol; 2010 Mar; 8(3):313. PubMed ID: 19788931
    [No Abstract]   [Full Text] [Related]  

  • 2. Efficacy of esophageal impedance/pH monitoring in patients with refractory gastroesophageal reflux disease, on and off therapy.
    Pritchett JM; Aslam M; Slaughter JC; Ness RM; Garrett CG; Vaezi MF
    Clin Gastroenterol Hepatol; 2009 Jul; 7(7):743-8. PubMed ID: 19281866
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
    Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
    Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caution about overinterpretation of symptom indexes in reflux monitoring for refractory gastroesophageal reflux disease.
    Slaughter JC; Goutte M; Rymer JA; Oranu AC; Schneider JA; Garrett CG; Hagaman D; Vaezi MF
    Clin Gastroenterol Hepatol; 2011 Oct; 9(10):868-74. PubMed ID: 21782769
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multichannel intraluminal impedance and pH monitoring in gastroesophageal reflux disease.
    Vela MF
    Expert Rev Gastroenterol Hepatol; 2008 Oct; 2(5):665-72. PubMed ID: 19072344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reflux monitoring: pH-metry, Bilitec and oesophageal impedance measurements.
    Pohl D; Tutuian R
    Best Pract Res Clin Gastroenterol; 2009; 23(3):299-311. PubMed ID: 19505660
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [pH-impedancemetry: clinical implications].
    Bertolini D; Roman S; Dumonceau JM
    Rev Med Suisse; 2008 Sep; 4(169):1873-4, 1876-8. PubMed ID: 18831408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The relevance of reflux monitoring off therapy.
    Savarino E; Zentilin P; Savarino V
    Am J Gastroenterol; 2011 Aug; 106(8):1558-9; author reply 1559. PubMed ID: 21811280
    [No Abstract]   [Full Text] [Related]  

  • 9. Reflux patterns in patients with short-segment Barrett's oesophagus: a study using impedance-pH monitoring off and on proton pump inhibitor therapy.
    Frazzoni M; Savarino E; Manno M; Melotti G; Mirante VG; Mussetto A; Bertani H; Manta R; Conigliaro R
    Aliment Pharmacol Ther; 2009 Sep; 30(5):508-15. PubMed ID: 19519732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laboratory based investigations for diagnosing gastroesophageal reflux disease.
    Dolder M; Tutuian R
    Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):787-98. PubMed ID: 21126694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pro: Impedance testing is useful in the management of GERD.
    Blondeau K; Tack J
    Am J Gastroenterol; 2009 Nov; 104(11):2664-6. PubMed ID: 19888230
    [No Abstract]   [Full Text] [Related]  

  • 12. Reflux monitoring: on or off therapy?
    Vaezi MF
    Am J Gastroenterol; 2011 Feb; 106(2):183-5. PubMed ID: 21301447
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impedance-pH monitoring in proton pump inhibitor resistant patients: ready for clinical application?
    Galmiche JP
    Gut; 2006 Oct; 55(10):1379-81. PubMed ID: 16966695
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial: persistent gastro-oesophageal reflux symptoms despite standard therapy with proton pump inhibitors - a follow-up study of intraluminal-impedance guided therapy.
    Becker V; Bajbouj M; Waller K; Schmid RM; Meining A
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1355-60. PubMed ID: 17900268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A balancing view: Impedance-pH testing in gerd-limited role for now, perhaps more helpful in the future.
    Shay S
    Am J Gastroenterol; 2009 Nov; 104(11):2669-70. PubMed ID: 19888232
    [No Abstract]   [Full Text] [Related]  

  • 16. Weakly acidic reflux.
    Tack J; Blondeau K
    Dig Dis; 2009; 27(1):58-61. PubMed ID: 19439962
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New developments in detection of gastroesophageal reflux.
    Emerenziani S; Sifrim D
    Curr Opin Gastroenterol; 2005 Jul; 21(4):450-3. PubMed ID: 15930987
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New developments in gastroesophageal reflux disease diagnosis and therapy.
    Ali T; Miner PB
    Curr Opin Gastroenterol; 2008 Jul; 24(4):502-8. PubMed ID: 18622167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gastroesophageal reflux disease--diagnosis and management].
    Wojtuń S; Gil J; Jałocha Ł; Błaszak A; Wojtkowiak M
    Pol Merkur Lekarski; 2009 May; 26(155):512-6. PubMed ID: 19606713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diagnosis and therapy of gastroesophageal reflux disease with lansoprazole].
    Bordin DS; Masharova AA
    Eksp Klin Gastroenterol; 2008; (5):85-90. PubMed ID: 19145922
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.